Vital Farms, Inc. (NASDAQ:VITL - Get Free Report) insider Matthew Ohayer sold 5,000 shares of the firm's stock in a transaction on Tuesday, June 17th. The stock was sold at an average price of $32.25, for a total value of $161,250.00. Following the transaction, the insider now directly owns 6,888,890 shares of the company's stock, valued at $222,166,702.50. The trade was a 0.07% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.
Matthew Ohayer also recently made the following trade(s):
- On Friday, June 13th, Matthew Ohayer sold 25,000 shares of Vital Farms stock. The shares were sold at an average price of $31.62, for a total value of $790,500.00.
- On Monday, April 21st, Matthew Ohayer sold 24,000 shares of Vital Farms stock. The stock was sold at an average price of $32.68, for a total value of $784,320.00.
- On Monday, March 24th, Matthew Ohayer sold 4,000 shares of Vital Farms stock. The shares were sold at an average price of $31.39, for a total transaction of $125,560.00.
- On Wednesday, March 19th, Matthew Ohayer sold 20,000 shares of Vital Farms stock. The stock was sold at an average price of $29.46, for a total transaction of $589,200.00.
Vital Farms Trading Up 6.6%
VITL stock traded up $2.11 during trading on Tuesday, reaching $34.32. 1,367,603 shares of the stock traded hands, compared to its average volume of 1,027,102. The firm has a market capitalization of $1.53 billion, a PE ratio of 30.64 and a beta of 0.89. The company has a debt-to-equity ratio of 0.04, a current ratio of 3.24 and a quick ratio of 2.81. The business's 50 day moving average price is $33.39 and its 200-day moving average price is $35.17. Vital Farms, Inc. has a 52-week low of $27.91 and a 52-week high of $48.41.
Vital Farms (NASDAQ:VITL - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.26 by $0.11. The business had revenue of $162.19 million for the quarter, compared to analyst estimates of $164.43 million. Vital Farms had a return on equity of 22.29% and a net margin of 8.68%. The company's revenue was up 9.7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.43 EPS. As a group, sell-side analysts forecast that Vital Farms, Inc. will post 1.11 earnings per share for the current year.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the business. CIBC Private Wealth Group LLC increased its position in shares of Vital Farms by 152.1% in the fourth quarter. CIBC Private Wealth Group LLC now owns 895 shares of the company's stock worth $35,000 after acquiring an additional 540 shares in the last quarter. Caitong International Asset Management Co. Ltd increased its holdings in Vital Farms by 20,650.0% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,660 shares of the company's stock valued at $51,000 after purchasing an additional 1,652 shares in the last quarter. US Bancorp DE raised its position in Vital Farms by 160.3% in the fourth quarter. US Bancorp DE now owns 1,416 shares of the company's stock valued at $53,000 after purchasing an additional 872 shares during the period. Frazier Financial Advisors LLC acquired a new position in shares of Vital Farms during the fourth quarter worth about $59,000. Finally, Principal Securities Inc. boosted its position in shares of Vital Farms by 29.4% in the fourth quarter. Principal Securities Inc. now owns 1,673 shares of the company's stock worth $63,000 after buying an additional 380 shares during the period. 98.59% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several analysts have commented on VITL shares. William Blair reaffirmed an "outperform" rating on shares of Vital Farms in a research note on Friday, February 28th. Morgan Stanley decreased their price objective on Vital Farms from $40.00 to $39.00 and set an "overweight" rating on the stock in a report on Thursday, April 17th. DA Davidson dropped their target price on Vital Farms from $44.00 to $42.00 and set a "buy" rating for the company in a research note on Friday, March 14th. BMO Capital Markets upgraded Vital Farms to a "strong-buy" rating in a research report on Tuesday, May 6th. Finally, Stifel Nicolaus raised Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 price target on the stock in a research note on Friday, February 28th. Eight equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Buy" and an average target price of $44.63.
View Our Latest Stock Report on Vital Farms
About Vital Farms
(
Get Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.